Nature Chemical Biology 'Under Review': What Each Status Means

The journal does not publish a list of its portal status labels, so treat the labels above as illustrative and follow the journal's emails.

Before the paper reaches external reviewers, a Nature Chemical Biology handling editor may consult with other editors to evaluate whether the chemistry-biology integration warrants formal review. The journal does not publish a current percentage rejected at this stage.

A desk rejection most often means the editors concluded that the work is strong in chemistry but weak in biology (or vice versa), has insufficient interdisciplinary framing, presents narrow specialist contributions without broad chemical biology significance, or packages where the chemistry-biology interface is not genuinely integrated. Common reasons for rejection at Nature Chemical Biology include all four of these patterns.

The Nature Chemical Biology editorial assistant checks that the manuscript and associated materials are complete: a manuscript file (including Methods, Figures and Extended Data if applicable), a cover letter, and optional supplementary information. The journal publishes no duration for this step.

The assigned editor reads the paper and evaluates chemistry-biology integration, broad chemical biology significance, methodological rigor, and Nature Portfolio family routing. The editor and the editorial team decide whether or not to send the manuscript out to review. The journal's median from submission to first editorial decision is 11 days.

The editor consults the editorial team before deciding whether to send the paper for peer review, so an ambiguous-fit paper can be discussed across the team. If the editors decline, the decision email carries a link to transfer the manuscript, before or after peer review, to another Nature Portfolio journal, for example Nature Chemistry, Nature Methods or Nature Communications.

If the paper is sent for review, the editor contacts researchers with relevant expertise. Nature Portfolio policy says formal review is typically to two or three reviewers, and sometimes more if special advice is needed. Finding reviewers with topic-matched expertise across the chemistry-biology boundary can take time, and the journal publishes no recruitment duration.

Once reviewers agree to review, timing varies with reviewer availability and the breadth of the chemistry-biology claim. Reviewers evaluate chemistry-biology integration, broad significance, methodological rigor, and reproducibility. Nature does not publish a status-by-status review-duration guarantee.

After reports return, the handling editor synthesizes them. The journal publishes no first-decision time for papers that reach external peer review; its median from submission to acceptance is 258 days.

The windows below are Manusights rules of thumb, not journal figures; the journal publishes no status-by-status durations.

• Rejection within 1 to 7 days: Administrative issue or immediate scope mismatch.

• Early rejection: Handling editor and editorial consultation found a scope, significance, or readiness mismatch. The journal's official median to first editorial decision is 11 days.

• Still Under Review after 4 weeks: A likely signal that the paper passed the Nature Chemical Biology filter, though a generic label is not proof.

• Still Under Review after 12 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the Manuscript Tracking System is appropriate.

• Status changes to "Decision Pending": Reports are likely in; the journal publishes no time from this status to a decision.

This is the most common anxiety we hear from Nature Chemical Biology authors during the active editorial window. The honest answer: no, 8 weeks at Under Review is not by itself a warning sign. The journal publishes no duration for the peer-review stage (its median from submission to acceptance is 258 days, which includes review and revision). Reports may still be arriving with the handling editor preparing to synthesize them.

Reviewer-driven delays can come from reviewer-recruitment timing or late reports; the journal publishes no figure for either.

If the portal still says Under Review at the 12-week mark, plausible explanations include a reviewer extension or a replacement reviewer being recruited. Neither is a signal about the decision.

What you should NOT do during the 8-to-12-week window is email the editorial office unless the journal's correspondence gave a timeframe that has passed; an early inquiry is unlikely to accelerate the timeline.

If your Nature Chemical Biology paper is rejected after review, the natural cascade depends on what the reviewers and handling editor cited:

Nature Chemistry is the natural Springer Nature cascade for chemistry-leaning chemical biology papers. Nature Portfolio supports manuscript-transfer with reviewer reports preserved. The Nature Chemistry Manuscript Tracking System at mts-nchem.nature.com handles submission; nchem@nature.com handles publisher-level inquiries.

Nature Methods is the Springer Nature cascade for methodology-focused chemical biology papers.

Nature Communications is the broader-scope Springer Nature cascade for chemical biology papers where the Nature Portfolio scope fits.

Communications Chemistry is the Nature Portfolio open-access cascade for chemistry papers where open-access fits.

JACS is the external ACS chemistry flagship cascade. JACS uses ACS Paragon Plus at ACS journal page; editorial contact jacs@acs.org.

Cell Chemical Biology is the external Cell Press cascade for chemistry-biology integration papers. Cell Press uses Editorial Manager at Editorial Manager submission portal; editorial contact cellchembio@cell.com.

Nature Portfolio asks reviewers about the key results, validity, originality and significance, data and methodology, statistics, conclusions, references, and clarity; it does not publish a four-item list. The table below maps four areas that matter for a chemistry-biology paper to actionable preparation (Manusights judgment).

In our pre-submission work with Nature Chemical Biology-targeted manuscripts, three named patterns generate the most consistent reviewer concerns and the most common reasons papers miss the editorial bar or fail the desk screen.

Unbalanced chemistry-biology framing flagged at handling editor screen. When the work is strong in chemistry but weak in biology (or vice versa), early rejection is a material risk. The strongest manuscripts demonstrate rigor on both sides of the chemistry-biology interface through matched synthetic characterization, cell or organism validation, controls, and figure logic that makes the bridge visible.

Check whether your Nature Chemical Biology bridge is balanced →

Side-by-side rather than integrated chemistry-biology framing flagged at desk screen. When the chemistry-biology interface is not genuinely integrated, handling editor desk rejection is common. The strongest manuscripts frame the chemistry-biology integration as a unified contribution in the title, abstract, schematic figure, results sequence, and discussion, so reviewers do not see a chemistry paper with biology validation appended at the end.

Check your chemistry-biology integration framing →

Cover-letter framing weakness flagged at desk screen. Editors do read cover letters at Nature Chemical Biology, and peer reviewers do not see them. When the cover letter does not name what is genuinely new at the chemistry-biology interface, handling editor desk rejection is common. The strongest cover letters explicitly name the integration novelty, the reader benefit, and the specific evidence package that supports both chemical characterization and biological relevance.

Check your Nature Chemical Biology cover-letter claim →

We have reviewed 50+ manuscripts targeting Nature Chemical Biology, Nature Chemistry, JACS, Cell Chemical Biology, Nature Methods, and Nature Communications. This guide tells you what Nature Chemical Biology editors look for in the status window, while the review tells you whether your paper passes the same chemistry-biology integration, characterization, assay-validation, and cover-letter checks before the handling editor or external reviewers see it. Full Manusights reviews include a 60-day money-back guarantee, and we do not train models on your manuscript.

In our pre-submission review work across chemical-biology, methods, and chemistry targets, Nature Chemical Biology-bound drafts most often failed when the chemistry was publishable and the biology was publishable, but the manuscript did not prove why the two belonged together. We see this as a recurring failure pattern because the handling editor can often see the side-by-side structure from the abstract, schematic, and first results figure.

Source limitation: official guidance explains Nature Chemical Biology submission policies and reporting requirements, but it cannot diagnose whether your specific chemistry-biology interface is integrated enough for this journal rather than Nature Chemistry, Nature Methods, JACS, or Cell Chemical Biology.

This page was created from Springer Nature's public Nature Chemical Biology editorial policies at Nature Portfolio journal page, Nature Chemical Biology submission guidelines, the current official 11-day first-editorial-decision median and 258-day submission-to-acceptance median, and Manusights pre-submission review experience with Nature Chemical Biology-targeted manuscripts. Nature does not publish a current acceptance or desk-rejection rate for this journal.

For the chemistry-biology interface landscape beyond Nature Chemical Biology, see Nature Chemistry (chemistry-leaning cascade), Nature Methods (methodology-focused cascade), Nature Communications (broader Nature Portfolio scope), Communications Chemistry (open-access cascade), JACS (broader ACS chemistry), and Cell Chemical Biology (Cell Press chemistry-biology integration).

The choice across these titles depends on whether the central contribution is top-tier chemistry-biology integration (Nature Chemical Biology), chemistry-leaning (Nature Chemistry), methodology-focused (Nature Methods), broader Nature Portfolio (Nature Communications), open-access chemistry (Communications Chemistry), broad ACS chemistry (JACS), or Cell Press chemistry-biology integration (Cell Chemical Biology).

Reviewers at Nature Chemical Biology are chosen for relevant expertise, and for a chemistry-biology paper the set often includes both chemistry and biology specialists. Editors screen and triage manuscripts before any reviewer sees them, and preparing a response template that addresses both chemistry and biology reviewer perspectives accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the Nature Chemical Biology chemistry-biology-integration bar before submission, our Nature Chemical Biology pre-submission diagnostic flags the framing and cover-letter weaknesses most likely to surface in reviewer reports.